Thrombocytopenia in chronic liver disease.
Peck-Radosavljevic M.
Liver Int. 2017 Jun;37(6):778-793. doi: 10.1111/liv.13317. Epub 2016 Dec 27.
Succinate is an inflammatory signal that induces IL-1β through HIF-1α.
Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O'Neill LA.
Nature. 2013 Apr 11;496(7444):238-42. doi: 10.1038/nature11986. Epub 2013 Mar 24.
Veno-occlusive Disease.
Willner IR.
Curr Treat Options Gastroenterol. 2002 Dec;5(6):465-469. doi: 10.1007/s11938-002-0034-x.
Spontaneous bacterial peritonitis.
Hoefs JC, Runyon BA.
Dis Mon. 1985 Sep;31(9):1-48. doi: 10.1016/0011-5029(85)90002-1.
High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.
Shinohara T, Moonen JR, Chun YH, Lee-Yow YC, Okamura K, Szafron JM, Kaplan J, Cao A, Wang L, Guntur D, Taylor S, Isobe S, Dong M, Yang W, Guo K, Franco BD, Pacharinsak C, Pisani LJ, Saitoh S, Mitani Y, Marsden AL, Engreitz JM, Körbelin J, Rabinovitch M.
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):218-237. doi: 10.1161/ATVBAHA.124.321092. Epub 2024 Dec 26.
Metabolic characterization of mouse bone marrow cells responsive to estrogenic inhibition: hexose monophosphate shunt enzyme activity in enriched populations of mature cells and progenitor cells.
Dieter MP, French JE, Boorman GA, Luster MI.
J Leukoc Biol. 1987 Mar;41(3):212-9. doi: 10.1002/jlb.41.3.212.
Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
Huang M, Feng Z, Ji D, Cao Y, Shi X, Chen P, Wang P, Tang M, Liu K.
Cytotherapy. 2014 Nov;16(11):1575-1583. doi: 10.1016/j.jcyt.2014.04.007.
Four-year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation.
Annaloro C, Robbiolo L, Pozzoli E, Ibatici A, Nicolini A, Salerno F, Deliliers GL.
Leuk Lymphoma. 2004 Jul;45(7):1485-7. doi: 10.1080/10428190410001663626.
Disturbed bone marrow cell proliferation in primary shunt hyperbilirubinemia.
Hamer JW, Fitzgerald PH.
Blood. 1973 Apr;41(4):539-47.
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Fried MW, Connaghan DG, Sharma S, Martin LG, Devine S, Holland K, Zuckerman A, Kaufman S, Wingard J, Boyer TD.
Hepatology. 1996 Sep;24(3):588-91. doi: 10.1002/hep.510240321.
